Evidence map›Paper›PMID 42377616›Full record

ReviewMolecular biology reports2026

Integrating single-cell RNA sequencing with multi-omics to decode disease microenvironments.

Arti Devi, Vaibhav Pathak, Vagish Dwibedi, Jasdeep Singh, Ashish Kumar Pathak, Nancy George, Ashwani Kumar, Gursharan Kaur, Santosh Kumar Rath, Amit Chatterjee

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arti DeviDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Vaibhav PathakDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Vagish DwibediDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India. vagishdwibedi@gmail.com.
Jasdeep SinghDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Ashish Kumar PathakDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Nancy GeorgeDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Ashwani KumarDepartment of Biotechnology, University Institute of Biotechnology, Chandigarh University, Mohali, 140413, India.
Gursharan KaurDepartment of Environmental Science and Technology, Thapar Institute of Engineering and Technology, Patiala, 147004, India.
Santosh Kumar RathSchool of Pharmaceuticals and Population Health Informatics, DIT University, Dehradun, Uttarakhand, 248009, India.
Amit ChatterjeeSchool of Computer Sciences and Technology, DIT University, Dehradun, Uttarakhand, 248009, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellular heterogeneity underpins the complexity of human development and disease, as cells with the same genome exhibit distinct transcriptomic profiles that define their identity, state, and function. Traditional bulk RNA sequencing obscures this heterogeneity by averaging gene expression across mixed cell populations, limiting its ability to resolve rare or disease-associated cell types. Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful technology enabling high-resolution transcriptomic profiling of thousands of individual cells in a single run. Widely adopted platforms, such as the 10x Genomics Chromium system, have accelerated large-scale single-cell studies through their scalability and robust barcoding strategies. Recent advances integrating scRNA-seq with multi-omics approaches, including epigenomics, spatial transcriptomics, and temporal profiling, have further enhanced our understanding of cellular interactions and disease mechanisms. In parallel, artificial intelligence-driven methods, including deep learning and graph-based models, have improved data denoising, clustering, and cell-type annotation. Despite these advances, technical noise, dropout events, and computational challenges remain. This review highlights the integration of single-cell RNA sequencing with multi-omics to decode disease microenvironments.

Indexed as

Sequence Analysis, RNASingle-Cell AnalysisAnimalsEpigenomicsGene Expression ProfilingGenomicsHumansMultiomicsSingle-Cell Gene Expression AnalysisSpatial TranscriptomicsTranscriptomeCellular heterogeneityImmunologyNeurological disordersOncologySingle-cell RNA sequencing (scRNA-seq)Transcriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.